Trial Profile
A Phase IIA Trial Testing the Efficacy of Bortezomib (Velcade) in Patients With Advanced Waldenstrom Macroglobulinemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2013
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 13 Nov 2008 New trial record.